We are live on ! Find out more
CMIIU

CM Life Sciences II Inc. Unit

Delisted

CMIIU was delisted on the 1st of September, 2021.

0 hedge funds and large institutions have $0 invested in CM Life Sciences II Inc. Unit in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 380 (-38)

100% less capital invested

Capital invested by funds: $237M → $0 (-$237M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 38

Holders
Holders Change
-38
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
38
Calls
Puts
Net Calls
Net Calls Change

CMIIU Hedge Fund Activity: Q3 2021 in Review

0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences II Inc. Unit (CMIIU) for Q3 2021, worth a combined $0 — down 100% from $237M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of CMIIU and 0 opened new positions — a net loss of 38 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was ARK Investment Management, exiting entirely with an estimated $38.3M sold.

  • 0 institutional investors held CM Life Sciences II Inc. Unit (CMIIU) as of Q3 2021, down from 38 in Q2 2021.
  • Funds reported $0 of CM Life Sciences II Inc. Unit stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new CM Life Sciences II Inc. Unit positions in Q3 2021 and 38 closed out, a net change of -38 holders.
  • The largest CM Life Sciences II Inc. Unit seller in Q3 2021 was ARK Investment Management, an estimated $38.3M sold.

Based on aggregated 13F filings for Q3 2021.